BR0104761A - Abamectin plus ivermectin combination for use as endectocide in cattle - Google Patents

Abamectin plus ivermectin combination for use as endectocide in cattle

Info

Publication number
BR0104761A
BR0104761A BR0104761A BR0104761A BR0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A BR 0104761 A BR0104761 A BR 0104761A
Authority
BR
Brazil
Prior art keywords
abamectin
ivermectin
endectocide
bovine
parasites
Prior art date
Application number
BR0104761A
Other languages
Portuguese (pt)
Inventor
Gustavo Henrique Nogueir Costa
Original Assignee
Inst De Pesquisa Em Saude Anim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Pesquisa Em Saude Anim filed Critical Inst De Pesquisa Em Saude Anim
Priority to BR0104761A priority Critical patent/BR0104761A/en
Publication of BR0104761A publication Critical patent/BR0104761A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"ASSOCIAçãO DE ABAMECTINA MAIS IVERMECTINA PARA USO COMO ENDECTOCIDA EM BOVINOS". A associação de duas lactonas macrocíclicas, a Abamectina e a Ivermectina, tendo como veículo álcool benzílico, Acetato de Tocoferol e óleo de oliva, atua como endectocida de grande espectro. Trata-se de uma formulação de longa ação, estável, que deve ser administrada via subcutânea, em dose única, no combate a parasitas de bovinos, tais como: nematódeos gastrintestinais e pulmonares, bernes, carrapatos, sarnas e miíases cutâneas. Esta associação resulta em melhor aproveitamento das características terapêuticas de cada uma das substâncias associadas, quando comparadas à utilização de cada uma delas isoladamente, resultando menor custo e conseq³entemente melhor relação custo/benefício, atendendo de forma adequada às necessidades do criador e à finalidade proposta, exterminando de forma adequada os parasitas que prejudicam os rebanhos bovinos, com menor toxicidade e, finalmente, aumentando a produtividade e lucratividade dos rebanhos."ABAMECTIN ASSOCIATION MORE IVERMECTIN FOR USE AS AN ENDECTOCID IN BOVINE". The combination of two macrocyclic lactones, Abamectin and Ivermectin, having benzyl alcohol, Tocopherol Acetate and olive oil as their vehicle, acts as a broad spectrum endectocide. It is a stable, long-acting formulation that should be administered subcutaneously, in a single dose, to combat bovine parasites such as gastrointestinal and pulmonary nematodes, berns, ticks, scabies and skin myiasis. This association results in a better use of the therapeutic characteristics of each of the associated substances, when compared to the use of each one of them, resulting in lower cost and consequently better cost / benefit ratio, adequately meeting the creator's needs and the proposed purpose, properly exterminating parasites that harm cattle herds with less toxicity and ultimately increasing the productivity and profitability of the herds.

BR0104761A 2001-08-08 2001-08-08 Abamectin plus ivermectin combination for use as endectocide in cattle BR0104761A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0104761A BR0104761A (en) 2001-08-08 2001-08-08 Abamectin plus ivermectin combination for use as endectocide in cattle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0104761A BR0104761A (en) 2001-08-08 2001-08-08 Abamectin plus ivermectin combination for use as endectocide in cattle

Publications (1)

Publication Number Publication Date
BR0104761A true BR0104761A (en) 2003-08-12

Family

ID=27625742

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104761A BR0104761A (en) 2001-08-08 2001-08-08 Abamectin plus ivermectin combination for use as endectocide in cattle

Country Status (1)

Country Link
BR (1) BR0104761A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037294A1 (en) * 2003-10-17 2005-04-28 Akzo Nobel N.V. Compositions for controlling parasites comprising a combination of abamectin and ivermectin
WO2007053760A3 (en) * 2005-11-01 2008-01-10 Dow Agrosciences Llc Pesticidally active compositions having enhanced activity

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005037294A1 (en) * 2003-10-17 2005-04-28 Akzo Nobel N.V. Compositions for controlling parasites comprising a combination of abamectin and ivermectin
AU2004281551B2 (en) * 2003-10-17 2009-10-29 Intervet International B.V. Compositions for controlling parasites comprising a combination of abamectin and ivermectin
CN1867341B (en) * 2003-10-17 2010-06-16 英特威国际有限公司 Compositions for controlling parasites comprising a combination of abamectin and milbemycin
WO2007053760A3 (en) * 2005-11-01 2008-01-10 Dow Agrosciences Llc Pesticidally active compositions having enhanced activity

Similar Documents

Publication Publication Date Title
Alley et al. Cutaneous toxicities of cancer therapy
Langtry et al. Sildenafil: a review of its use in erectile dysfunction
AR024516A1 (en) BI-AROMATIC COMPOUNDS ANALOGS OF VITAMIN D, ITS USE, PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION THAT INCLUDE AT LEAST ONE OF SUCH COMPOUNDS AND USE OF SUCH COSMETIC COMPOSITION.
DE60120659D1 (en) COMPOSITIONS CONTAIN CAROTENOIDS AND THEIR USE TO PREVENT HORMON-INDUCED SIDE EFFECTS
BR0209658A (en) 4-Amino-5-phenyl-7-1-cyclobutyl-pyrrolo [2,3-d] pyrimidine derivatives
TR200001891T2 (en) ASPB28- Human insulin and its use.
BRPI0512311A (en) use of meloxicam in veterinary medicine for the treatment of painful inflammatory diseases
BRPI0410503B8 (en) topical composition and use of composition
ATE226815T1 (en) MANUFACTURING OF MEDICINAL PRODUCTS
PT1207756E (en) USE OF ESPINOSADE OR A FORMULATION THAT INCLUDES ESPINOSADE
KR920007629A (en) A pharmaceutical composition exhibiting activity in the treatment of neurological diseases of AIDS patients by containing at least one compound selected from SALMe salt, 5-MTHF and 5-FTHF as an active ingredient.
BRPI0411165A (en) pharmaceutical composition, dosage unit form and methods for preparing its use
BR0318319A (en) preparation methods and formulations / compositions sustained by the use of dimethicone as a vehicle
BR0110060A (en) Transdermal or transmucosal pharmaceutical dosage form for the treatment of nicotine addiction or to accustom smokers and use of the dosage form
DE602006009259D1 (en) PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL
DE69229318D1 (en) Hydrogenated castor oil-containing injectable formulations with extended drug delivery
MXPA04011990A (en) Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same.
BR0015770A (en) Bicyclic analogues of vitamin D, use of a compound, pharmaceutical composition, cosmetic composition and use of a cosmetic composition
MXPA05013270A (en) Transmucosal form of administration with reduced mucosal irritation.
ES2174533T3 (en) USE OF A MIXTURE OF A DIOL AND AN ALFA-HYDROXY ACID FOR THE TREATMENT OF HYPERQUERATOTIC SKIN DISEASES.
BR0104761A (en) Abamectin plus ivermectin combination for use as endectocide in cattle
BR0313503A (en) Restless Leg Syndrome Treatment Method, Adenoin a2a Receptor Antagonist Use, Therapeutic Agent for Restless Leg Syndrome, and Night Myoclonus Treatment Method
Knight et al. A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB)
BR0212744A (en) Cisplatin formulations of reduced toxicity and methods for their use
BRPI0507144A (en) powder formulations

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: REFERENTE A RPI 1812

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B25C Requirement related to requested transfer of rights

Owner name: INSTITUTO DE PESQUISA EM SAUDE ANIMAL LTDA. (BR/MG

Free format text: A FIM DE ATENDER A(S) TRANSFERENCIA(S), REQUERIDA(S) ATRAVES DA PETICAO NO 020130026576- RJ, DE 28/03/2013, E NECESSARIO APRESENTAR O CONTRATO SOCIAL DA EMPRESA CEDENTE PARA VERIFICAR SE O ASSINANTE DO DOCUMENTO DE CESSAO TEM PODERES PARA ALIENAR BENS.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: INTERVET INTERNATIONAL B.V. (NL)